Marks Group Wealth Management »

Ascendis Pharma A S shares owned by Marks Group Wealth Management

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Marks Group Wealth Management from 13F filings

Historical chart of Marks Group Wealth Management investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Marks Group Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Marks Group Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $901k 3.9k 228.73

More positions owned by Marks Group Wealth Management

Ishares Tr Eafe Value Etf (EFV)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Spdr Series Trust State Street Spd (SPYM)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Core Msci Emkt (IEMG)
Putnam Etf Trust Focused Lar Cap (PVAL)
Ishares Tr S&p 500 Grwt Etf (IVW)
Microsoft Corporation (MSFT)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Republic Services (RSG)
NVIDIA Corporation (NVDA)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Meta Platforms Cl A (META)
Intercontinental Exchange (ICE)

View all positions for Marks Group Wealth Management

Top funds holding Ascendis Pharma A S

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
FMR
Artisan Partners Limited Partnership
Franklin Resources
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Wellington Management Company
T. Rowe Price Investment Management
Perceptive Advisors
American Century Companies
Capital World Investors
Principal Financial Group
Ameriprise Financial

View all funds holding Ascendis Pharma A S